Merck Announces Winners of 2018 Life Science Awards

• Twelve student finalists awarded in three fields: bioseparations, food & beverage safety and tumor biology
• Grand prize winners Yu Cai, University of Colorado; Yanqi Qu, University of Massachusetts Amherst and Jun Ho Lee, Ulsan National Institute of Science and Technology, each awarded $10,000

Darmstadt, Germany, November 19, 2018 — Merck, the vibrant science and technology company, recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.

Twelve finalists from across the globe (four in each of three awards categories: bioseparations, food & beverage safety, and tumor biology) presented their research to an audience of Merck scientists, and guests as part of the 2018 Life Science Awards. Yu Cai, Yanqi Qu and Jun Ho Lee were each named winners of the $10,000 grand prize in their respective categories.

“This year’s Life Science Award winners generated new insights into areas of deep interest to the applied sciences,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “Each winner is not only a good scientist, they are curiously solving the toughest problems in life science,” he added.

Following is a list of the grand prize winners and their research topics:

• Yu Cai, University of Colorado, “Real-time observations of nanoparticles in filtration membranes,” bioseparations winner.
• Yanqi Qu, University of Massachusetts Amherst, “Safety and quality analysis of alcoholic and non-alcoholic beverages using surface-enhanced Raman scattering,” food and beverage safety winner.
• Jun Ho Lee, Ulsan National Institute of Science and Technology, “TonEBP promotes hepatocellular carcinoma development, therapeutic resistance and recurrence via inflammation and liver cancer stem cells,” tumor biology winner.

Finalists receiving $2,000 prizes were:

Bioseparations

• Daniel Burgstaller, University of Natural Resources and Life Sciences Vienna, “Flocculation assisted primary separation and product capture by precipitation – How do we get it continuous?”
• Ashton Lavoie, North Carolina State University, “Mixed-mode peptide ligands for improved clearance of CHO host cell proteins.”
• Ujwal Patil, University of Houston, “Real-time monitoring of antibody in column breakthrough.”

Food & Beverage Safety

• Imanuel Yüce, Justus Liebig University of Giessen, “Development of in situ and in silico tools as well as improvement of classical techniques for structure elucidation in planar chromatography.”
• Anna Sophia Harrand, Cornell University, “Effects of strain diversity and growth conditions on subsequent bacterial growth.”
• Shaoakang Zhang, University of Georgia, “Whole genome sequencing, a one-stop platform for foodborne pathogen subtyping, characterization and detection.”

Tumor Biology

• Jan Lumibao, University of Illinois Urbana, Champaign, “Functional capacity of CHCHD2 in glioblastoma cells expressing EGFRvIII.”
• Christina Mertens, Goethe-University Frankfurt, “Role of lipocalin-2 from tumor-associated macrophages as alternative iron transporter during tumor growth.”
• Silvia Duarte Sanmiguel, Ohio State University, “Nanotechnology-based approaches towards elucidating and modulating the immunology of the tumor niche.”

Follow Merck on Twitter @Merckgroup, on Facebook @merckgroup and on LinkedIn.

メルクについて
Merck（メルク）はヘルスケア、ライフサイエンス、パフォーマンスマテリアルズの分野における世界有数のサイエンスとテクノロジー企業です。がんや多発性硬化症のためのバイオ医薬品を用いた治療法から、科学研究と生産に関する最先端システム、スマートフォンや液晶テレビ向けの液晶材料にいたるまで、約53,000人の従業員が人々の暮らしをより良くする技術の一層の進歩を目指しています。2017年は66カ国で153億ユーロの売上高を計上しました。

メルクは1668年に創業された世界で最も歴史の長い医薬・化学品会社で、 創業家が今でも、上場企業が率いるメルクグループの株式の過半数を所有しています。メルクの名称およびブランドのグローバルな権利は、メルクが保有しています。唯一の例外は米国とカナダで、両国ではEMDセローノ、ミリポアシグマ、EMDパフォーマンスマテリアルズとして事業を行っています。